Skip to main content
. 2015 Aug 13;6(8):e1854. doi: 10.1038/cddis.2015.226

Figure 6.

Figure 6

GADD45β-I inhibits MKK7 activation 3 h post lesion. Western blotting and relative quantification of contralateral and ipsilateral brain samples. Animals were pre-treated with GADD45β-I (11 mg/kg 30 min before MCAO) and killed 3 and 6 h after lesion. (a) Western blotting and relative quantification of P-MKK7/MKK7 ratio 3 h after lesion. Actin was used as loading control. Data are presented as mean±S.E.M. (two-way ANOVA, Tukey's post-hoc test *P<0.05, n=3) (b) Western blotting and relative quantification of P-MKK7/MKK7 6 h after lesion. Actin was used as loading control. Data are presented as mean±S.E.M. (two-way ANOVA, Tukey's post-hoc test *P<0.05, n=3) (c) Western blotting and relative quantification of P-JNK/JNK ratio 6 h after lesion. Actin was used as loading control. Data are presented as mean±S.E.M. (two-way ANOVA, interaction >0.05, n=3) (d) Western blotting and relative quantification of P-MKK4/MKK4. Actin was used as loading control. Data are presented as mean±S.E.M. (two-way ANOVA, interaction >0.05, n=3)